Principal Investigator
Michele Stanchina
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20240836
Clinical Trial Summary
Randomized Phase III Study of Mosunetuzumab vs. Rituximab for Low Tumor Burden Follicular Lymphoma
Phase
Phase III
Funding Agency/Sponsor
National Cooperative Group
Disease
Lymphoma
Contact Information
Phone Number
+1 (305) 2437261